# Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals

> **NCT06875245** · PHASE4 · RECRUITING · sponsor: **Faculty Hospital Kralovske Vinohrady** · enrollment: 100 (estimated)

## Conditions studied

- Wet Age-related Macular Degeneration

## Interventions

- **DRUG:** Faricimab Injection

## Key facts

- **NCT ID:** NCT06875245
- **Lead sponsor:** Faculty Hospital Kralovske Vinohrady
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-31
- **Primary completion:** 2025-04
- **Final completion:** 2026-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06875245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06875245, "Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06875245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*